Navigation Links
Pfizer to Present More Than 40 Abstracts on Pre-Clinical, Clinical and Outcomes Research at Alzheimer's Association International Conference on Alzheimer's Disease
Date:7/8/2010

NEW YORK, July 8 /PRNewswire-FirstCall/ -- Pfizer Inc. (NYSE: PFE) will present new data on its investigational compounds targeting various aspects of Alzheimer's disease (AD), a complex degenerative brain disorder.  New findings on the role of comorbidities, the burden of care and costs associated with AD, also will be discussed. These data, some in collaboration with our partners, will be presented at the Alzheimer's Association International Conference on Alzheimer's Disease 2010 (ICAD 2010) in Honolulu, July 10-15.  

(Logo:  http://photos.prnewswire.com/prnh/20100416/PFIZERLOGO )

(Logo:  http://www.newscom.com/cgi-bin/prnh/20100416/PFIZERLOGO )

"Biomedical research and development is very risky; for every new medicine that makes it to market, thousands must be screened in discovery. For a complex condition such as Alzheimer's disease, which has multiple factors contributing to its onset and progression, the challenges are even greater," said Steve Romano, vice president, medical affairs head, Pfizer Primary Care Business Unit.  "The breadth of data being presented at ICAD
'/>"/>

SOURCE Pfizer Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Wyeths Torisel and Roche/Genentechs Avastin Will Challenge Pfizers Sutent to Become the Clinical Gold Standard for Treatment of Metastatic Renal Cell Carcinoma
2. Kosans Motilin Receptor Agonist, Licensed to Pfizer, Enters Phase 1 Clinical Trial in Gastroesophageal Reflux Disease
3. Coley Pharmaceutical Group and Pfizer Nominate Additional Anti-Cancer Compound for Clinical Development
4. Rigel Announces Initiation of Phase 1 Clinical Trial of R343 for Allergic Asthma by its Partner Pfizer
5. NicOx Announces Pfizer Initiates Phase 2 Clinical Development for PF-03187207 in Japan
6. Tacere Therapeutics Enters Collaboration and License Agreement With Pfizer To Develop and Commercialize RNAi Hepatitis C Drug
7. MannKind Addresses Pfizers Announcement Regarding Exubera
8. Quark Pharmaceuticals Announces First Patient Dosing by Pfizer in Phase II Trial of RNAi Therapy in Diabetic Macular Edema
9. Silence Therapeutics to Receive $1.9m Milestone Payment as Pfizer and Quark Commence Phase II Trial
10. Medarex Receives Milestone Payment from Pfizer for Investigational New Drug Application Filing
11. Pfizer Contributes Critical Data to URMC Drug Safety Initiative
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... -- Foundation Health Care  (FDNH), which owns and operates hospitals ... it will present at the LD Micro Invitational Conference ... Boulevard Hotel, Los Angeles, CA. ... at 3:00pm and will also be available for ... LD Micro. For more information about the conference, please ...
(Date:5/27/2015)... , May 27, 2015  Genomic Health, Inc. (Nasdaq: ... Operating Officer and Chief Financial Officer, will present at the ... City on Monday, June 1 at 8:30 a.m. ... subsequently archived webcast of the presentation, go to the  Investor ... .  Please connect to the web site at least 15 ...
(Date:5/27/2015)... , May 25, 2015 Research and Markets ... the "Research and Future Development Trend Forecast of ... At present, there are 35,600 dialysis centers ... ratio are large due to the different regional operating ... centers in other Asian countries are operated by state-owned ...
Breaking Medicine Technology:Genomic Health to Present at the Jefferies 2015 Global Healthcare Conference 2Genomic Health to Present at the Jefferies 2015 Global Healthcare Conference 3China Dialysis Market Report: Research and Future Development Trends and Forecasts 2015-2020 2
... 19, 2011 ICAP Patent Brokerage , ... intellectual property brokerage and patent auction firm, is ... major medical device company. The available portfolios disclose ... control, high-intensity focused ultrasound (HIFU) energy, improved blood ...
... SAN DIEGO, Oct. 19, 2011 CareFusion (NYSE: ... following update regarding its recall of 128 EnVe™ ventilators affecting ... Class I recall. The voluntary recall only ... and therefore, has no affect on the company,s current product ...
Cached Medicine Technology:Global Leader in Medical Technology Offers for Sale Seven Patent Portfolios Through ICAP Patent Brokerage 2Global Leader in Medical Technology Offers for Sale Seven Patent Portfolios Through ICAP Patent Brokerage 3CareFusion Initiates Class I Recall of EnVe Ventilators 2
(Date:5/27/2015)... May 27, 2015 NOVAtime Technology, ... Workforce Management solutions for enterprise organizations, announced today ... solution to automate its time, attendance and point ... locations in the United States. , Family-owned ... supplier of 21 retail, private label, and mill ...
(Date:5/27/2015)... 27, 2015 The MedSpa at Hendrick ... dermal filler treatments in Abilene, Texas: Xeomin®, Belotero Balance® ... appearance of glabellar lines, better known as the lines ... is designed to treat smoker’s lines around the mouth ... while Radiesse® improves the appearance of smile lines or ...
(Date:5/27/2015)... IL (PRWEB) May 27, 2015 On ... North-based advertising agency, will partner with LifeSource to host ... event will take place in a LifeSource donor coach ... a.m. to 4:00 p.m. , Demand for whole blood ... in Illinois, during the summer months. LifeSource requires approximately ...
(Date:5/27/2015)... With InnerVoice Communication App you ... message is not only heard but seen -- by a ... motivating image. This award-winning and affordable app takes full advantage ... using InnerVoice Sender app in conjunction with InnerVoice ... learner remotely for no additional cost. , InnerVoice Sender ...
(Date:5/27/2015)... 27, 2015 A television program using ... and Roswell Park Cancer Institute winning ... award-winning story, Cancer Can’t Win , highlights the ... Cancer Institute. The production team followed five people who ... as they received treatment from doctors and medical experts ...
Breaking Medicine News(10 mins):Health News:SanMar Corporation Successfully Implemented NOVAtime Workforce Management Solution across 9 locations 2Health News:SanMar Corporation Successfully Implemented NOVAtime Workforce Management Solution across 9 locations 3Health News:The MedSpa at Hendrick Introduces Xeomin®, Belotero Balance® and Radiesse® Injectables 2Health News:Donate Your Break and Save Lives at the River North Blood Drive 2Health News:Newly Released: InnerVoice Sender App Ups the Ante in Communication Technology for Autism with Remote Prompting 2Health News:Newly Released: InnerVoice Sender App Ups the Ante in Communication Technology for Autism with Remote Prompting 3Health News:Newly Released: InnerVoice Sender App Ups the Ante in Communication Technology for Autism with Remote Prompting 4Health News:MediaSource Wins New York Emmy® Award as Premier Health Care Storytellers 2Health News:MediaSource Wins New York Emmy® Award as Premier Health Care Storytellers 3
... demonstrated for the first time that it is possible to ... Cytomegalovirus (CMV). The virus, which is found in a wide ... tumour growth and reducing the size of the tumour as ... a common virus that is found in 70-75 per cent ...
... Reporter , MONDAY, Sept. 26 (HealthDay News) -- Coffee lovers, take ... daily seem to have a lower risk of depression than those ... a new study suggests. Although it,s way too early to ... the findings may comfort those who feel guilty about their habit. ...
... hormone replacement therapy (HRT) may have an increased risk ... A new study, which will be presented today (27 ... in Amsterdam, adds to the debate over the health ... menopause. Previous studies have found a link ...
... By Amanda Gardner HealthDay Reporter , MONDAY, ... cautionary note Monday about an increased risk of blood clots ... as Yaz or Yasmin. Although stopping short of a ... say it "remains concerned" about a potentially higher risk of ...
... Alan Mozes HealthDay Reporter , MONDAY, Sept. 26 ... Dinora Rodriguez. "It was a nightmare." Rodriguez had woken ... not move her arms or even close her eyes. And ... case involving breast implants and a facial scar, gone terribly ...
... Amanda Gardner HealthDay Reporter , MONDAY, Sept. 26 ... with smaller brain size and more problems with thinking skills ... of people who suffer from B-12 deficiencies may be greater ... vitamin may not be accurate, said Christine C. Tangney, lead ...
Cached Medicine News:Health News:Treatment of common virus can reduce tumour growth 2Health News: Lots of Coffee Might Lower Depression Risk: Study 2Health News: Lots of Coffee Might Lower Depression Risk: Study 3Health News:HRT therapy appears to increase risk of hospitalization from severe asthma attacks 2Health News:Newer Contraceptive Pills Could Raise Clot Risk, FDA Warns 2Health News:Check Plastic Surgeon's Credentials or Risk Tragic Results, Experts Warn 2Health News:Check Plastic Surgeon's Credentials or Risk Tragic Results, Experts Warn 3Health News:Check Plastic Surgeon's Credentials or Risk Tragic Results, Experts Warn 4Health News:Could Too Little Vitamin B-12 Shrink the Aging Brain? 2Health News:Could Too Little Vitamin B-12 Shrink the Aging Brain? 3
... VH series, it is a ... independent C-arms and image intensifiers, ... for Cardiovascular and Angiography. There ... the examinations for cerebral, cardiac, ...
This catheter is intended for ultrasound examination of coronary intravascular pathology ONLY. Intravascular ultrasound imaging is indicated in patients who are candidates for transluminal coronary i...
Rubidium Rb 82 Generator. ,The only generator-based Positron Emission Tomography agent reimbursed for the evaluation of coronary artery disease....
Kit for the Preparation of Technetium Tc 99m Teboroxime...
Medicine Products: